Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Dysuria in Multiple Sclerosis
NCT05439902Recruiting
- Sponsor
- CHU Nîmes
- Start
- Oct 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in dysuria comparing Tamsulosin First with Placebo First (2 arms). Primary endpoint: Urinary symptoms assessed by IPSS and USP scores at Day 90. Started Oct 2022; status: recruiting.
02
Drugs
tamsulosin
03
Conditions
dysuria
Beyond the preview
Go deeper on NCT05439902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05439902.